PortfoliosLab logoPortfoliosLab logo
EVT.DE vs. MRK
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

EVT.DE vs. MRK - Performance Comparison

The chart below illustrates the hypothetical performance of a €10,000 investment in Evotec SE (EVT.DE) and Merck & Co., Inc. (MRK). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Different Trading Currencies

EVT.DE is traded in EUR, while MRK is traded in USD. To make them comparable, the MRK values have been converted to EUR using the latest available exchange rates.

Returns By Period

In the year-to-date period, EVT.DE achieves a -14.31% return, which is significantly lower than MRK's 14.63% return. Over the past 10 years, EVT.DE has underperformed MRK with an annualized return of 2.44%, while MRK has yielded a comparatively higher 11.11% annualized return.


EVT.DE

1D
0.86%
1M
-10.71%
YTD
-14.31%
6M
-10.19%
1Y
-28.59%
3Y*
-39.65%
5Y*
-33.75%
10Y*
2.44%

MRK

1D
1.74%
1M
-3.37%
YTD
14.63%
6M
15.35%
1Y
52.48%
3Y*
1.82%
5Y*
13.30%
10Y*
11.11%
*Multi-year figures are annualized to reflect compound growth (CAGR)

EVT.DE vs. MRK - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
EVT.DE
Evotec SE
-14.31%-33.54%-61.47%39.45%-64.09%40.36%31.37%32.78%28.59%81.45%
MRK
Merck & Co., Inc.
14.63%-3.24%-0.07%-2.02%58.68%9.37%-14.85%25.03%46.52%-13.59%

Correlation

The correlation between EVT.DE and MRK is 0.03, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.03

Correlation (3Y)
Calculated over the trailing 3-year period

0.02

Correlation (5Y)
Calculated over the trailing 5-year period

0.01

Correlation (10Y)
Calculated over the trailing 10-year period

0.08

Correlation (All Time)
Calculated using the full available price history since Sep 17, 2007

0.12

The correlation between EVT.DE and MRK shifts across timeframes, from 0.01 (5 years) to 0.12 (all time), reflecting how their relationship changes across market environments.

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

EVT.DE vs. MRK — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

EVT.DE
EVT.DE Risk / Return Rank: 1919
Overall Rank
EVT.DE Sharpe Ratio Rank: 1919
Sharpe Ratio Rank
EVT.DE Sortino Ratio Rank: 2121
Sortino Ratio Rank
EVT.DE Omega Ratio Rank: 2121
Omega Ratio Rank
EVT.DE Calmar Ratio Rank: 1919
Calmar Ratio Rank
EVT.DE Martin Ratio Rank: 1616
Martin Ratio Rank

MRK
MRK Risk / Return Rank: 8888
Overall Rank
MRK Sharpe Ratio Rank: 8888
Sharpe Ratio Rank
MRK Sortino Ratio Rank: 8888
Sortino Ratio Rank
MRK Omega Ratio Rank: 8484
Omega Ratio Rank
MRK Calmar Ratio Rank: 9191
Calmar Ratio Rank
MRK Martin Ratio Rank: 8989
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

EVT.DE vs. MRK - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Evotec SE (EVT.DE) and Merck & Co., Inc. (MRK). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


EVT.DEMRKDifference
Sharpe ratioReturn per unit of total volatility

-2.48

Sortino ratioReturn per unit of downside risk

-3.32

Omega ratioGain probability vs. loss probability

0.94

1.34

-0.40

Calmar ratioReturn relative to maximum drawdown

-0.64

4.44

-5.07

Martin ratioReturn relative to average drawdown

-1.16

11.71

-12.87

EVT.DE vs. MRK - Sharpe Ratio Comparison

The current EVT.DE Sharpe Ratio is -0.53, which is lower than the MRK Sharpe Ratio of 1.95. The chart below compares the historical Sharpe Ratios of EVT.DE and MRK, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

EVT.DE vs. MRK - Drawdown Comparison

The maximum EVT.DE drawdown since its inception was -90.92%, which is greater than MRK's maximum drawdown of -57.34%. Use the drawdown chart below to compare losses from any high point for EVT.DE and MRK.


Loading charts...

Drawdown Indicators


EVT.DEMRKDifference

Max Drawdown

Largest peak-to-trough decline

-90.92%

-57.34%

-33.58%

Max Drawdown (1Y)

Largest decline over 1 year

-44.77%

-11.88%

-32.89%

Max Drawdown (3Y)

Largest decline over 3 years

-83.00%

-45.77%

-37.23%

Max Drawdown (5Y)

Largest decline over 5 years

-90.92%

-45.77%

-45.15%

Max Drawdown (10Y)

Largest decline over 10 years

-90.92%

-45.77%

-45.15%

Current Drawdown

Current decline from peak

-89.70%

-12.83%

-76.87%

Average Drawdown

Average peak-to-trough decline

-39.10%

-15.47%

-23.63%

Ulcer Index

Depth and duration of drawdowns from previous peaks

24.72%

4.49%

+20.23%

Volatility

EVT.DE vs. MRK - Volatility Comparison

Evotec SE (EVT.DE) has a higher volatility of 12.08% compared to Merck & Co., Inc. (MRK) at 9.96%. This indicates that EVT.DE's price experiences larger fluctuations and is considered to be riskier than MRK based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


EVT.DEMRKDifference

Volatility (1M)

Calculated over the trailing 1-month period

12.08%

9.96%

+2.12%

Volatility (6M)

Calculated over the trailing 6-month period

39.58%

18.68%

+20.90%

Volatility (1Y)

Calculated over the trailing 1-year period

53.52%

27.14%

+26.38%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

57.96%

24.62%

+33.34%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

51.34%

23.95%

+27.39%

Dividends

EVT.DE vs. MRK - Dividend Comparison

EVT.DE has not paid dividends to shareholders, while MRK's dividend yield for the trailing twelve months is around 3.07%.


PositionTTM20252024202320222021202020192018201720162015
EVT.DE
Evotec SE
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
MRK
Merck & Co., Inc.
3.07%3.12%3.14%2.72%2.52%3.41%3.03%2.48%2.60%3.36%3.14%3.43%

Financials

EVT.DE vs. MRK - Financials Comparison

This section allows you to compare key financial metrics between Evotec SE and Merck & Co., Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Please note, different currencies. EVT.DE values in EUR, MRK values in USD

Frequently Asked Questions


EVT.DE and MRK have a correlation of 0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for EVT.DE and MRK

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer